Spontaneous vemurafenib resistant A375 Melanoma Clones
| Inventor | Institute |
|---|---|
| Christoper Stipp | University Of Iowa Research Foundation |
| SKU: | 161796 |
|---|---|
| Product description: | Spontaneous vemurafenib resistant A375 Melanoma Clones. Shows frequent alterations of BRAF^V600 protein along with the expression of a truncated BRAF^V600E protein due to a aberrant splice event between exons 1 and 11 in the clone. No increased VAV1 protein levels. |
| Alternate name: | C5.1 |
| Gender: | Female |
| Production details: | Long-term cultures of A375 cells in 3 ?M vemurafenib. Spontaneous vemurafenib-resistant clones and populations were created after 23 and 46 weeks cultured in 3 mm vemurafenib. Maintained in media with 3 mm vemurafenib. |
| Parental cell line: | A375 Melanoma (ATCC) |
| Cat. #: | 161796 |
|---|---|
| Cancer types: | Skin cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Skin |
| Gender: | Female |
| Morphology: | Compact Morphology |
| Primary citation: | Feddersen et al.2019. Cancer Res. 79(19). PMID: 31416848 |
| Shipping conditions: | Dry Ice |
|---|---|
| Growth medium: | DMEM(Gibco) suplemented with penicillin/streptomycin (Gibco) and 10% FBS (Gibco). |
| References: |
Feddersen et al.2019. Cancer Res. 79(19).PMID: 31416844 Zhu et al. 2022. npj Precis. Onc. PMID: 36271146 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.